OVULATION TEST KIT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Growing preference for natural conception

Rising preference for natural conception without medical can drive the market growth. More couples are turning to ovulation test kits to track the timing of ovulation and increase their chances of conceiving naturally. Many people view natural conception as a more intimate experience than relying on assisted reproductive technologies. There is also a perception that it may reduce risks, costs and side effects as compared to treatments like IVF. Furthermore, lifestyle changes amid the COVID-19 pandemic provided many couples ample time to focus on their family planning goals in a relaxed setting. This environment has made home-based solutions like ovulation test kits more attractive. As a result, the sales of ovulation test kits have been increased over the last few years. According to the data published by the United Nations Department of Economic and Social Affairs, around 1.9 million couples in the U.S. alone were unable to conceive in 2020 and tried self-monitoring and home remedies before seeking medical help. This represents an increase of almost 15% compared to 2018 levels. Similar trend has been observed in several European countries as well as China and India. Fertility rates are declining worldwide even as the desire to start families remains intact. This unmet need as well as the convenience and privacy offered by ovulation test kits can boost their adoption. At the same time, progressive normalization of conversations around fertility and family planning has removed much of the stigma around these products.

• Clearblue
• ClinicalGuard
• Wondfo
• AccuMed
• PREGMATE
• iProven
• Wellify (Piramal group)
• Femometer
• Proov
• Easy@Home Fertility
• Fairhaven Health
• Mankind pharma
• First Response
• Sugentech
• Geratherm Medical AG